본문으로 건너뛰기
← 뒤로

mA methylation dependent autophagy activation is required for anti-tumor effects of artesunate through ferroptosis in hepatocellular carcinoma.

Chemico-biological interactions 2026 Vol.427() p. 111950

Li Y, Shen M, Li M, Qiu Y, Wang Y, Shao J, Xuan J, Zheng S, Zhang Z

📝 환자 설명용 한 줄

[BACKGROUND & AIMS] Artesunate (Art), a semisynthetic derivative of Artemisinin isolated from the traditional Chinese medicinal plant Artemisia annua L., has recently emerged as a candidate agent for

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Li Y, Shen M, et al. (2026). mA methylation dependent autophagy activation is required for anti-tumor effects of artesunate through ferroptosis in hepatocellular carcinoma.. Chemico-biological interactions, 427, 111950. https://doi.org/10.1016/j.cbi.2026.111950
MLA Li Y, et al.. "mA methylation dependent autophagy activation is required for anti-tumor effects of artesunate through ferroptosis in hepatocellular carcinoma.." Chemico-biological interactions, vol. 427, 2026, pp. 111950.
PMID 41621698

Abstract

[BACKGROUND & AIMS] Artesunate (Art), a semisynthetic derivative of Artemisinin isolated from the traditional Chinese medicinal plant Artemisia annua L., has recently emerged as a candidate agent for hepatocellular carcinoma (HCC) therapy. Although accumulating preclinical evidence suggests its potent antitumor efficacy against HCC, the precise molecular mechanisms underlying its therapeutic effects remain poorly characterized. This investigation employs a multimodal approach to delineate the pharmacodynamic mechanism of Art in HCC pathogenesis, while establishing a mechanistic foundation for developing targeted combination therapies against this malignancy.

[METHODS] In vitro metastatic potential was quantified through standardized wound-healing assays and Matrigel-based transwell invasion systems. Autophagic flux dynamics and ferroptosis biomarkers were systematically profiled using commercial assay kits coupled with live-cell confocal imaging and Western blot. Mechanistic interrogation employed RIP-seq analysis and dual-luciferase reporter systems with in situ mutation controls. In vivo therapeutic efficacy was validated using orthotopic HCC xenograft models in immunocompromised BALB/c nude mice.

[RESULTS] Art demonstrated antitumor efficacy, significantly attenuating HCC cell motility and suppressing orthotopic xenograft growth. Mechanistic profiling revealed Art-induced ferroptosis through autophagy, mediated by mA-dependent post-transcriptional regulation. Specifically, Art enhanced WTAP-mediated deposition of mA modifications at the RRACH motif of ATG5 mRNA, facilitating YTHDC2-dependent translation. This epitranscriptomic reprogramming increased ATG5 protein synthesis, triggering autophagy dependent ferritin degradation and subsequent ferroptosis.

[CONCLUSION] Art emerges as a clinically potential HCC therapeutic that elicits its oncosuppressive activity through WTAP/YTHDC2-mediated mA methylation of ATG5 transcripts, thereby causes ferroptosis of HCC mediated by autophagy.

MeSH Terms

Ferroptosis; Artesunate; Humans; Carcinoma, Hepatocellular; Liver Neoplasms; Animals; Autophagy; Mice; Mice, Nude; Mice, Inbred BALB C; Antineoplastic Agents; Cell Line, Tumor; Xenograft Model Antitumor Assays; Cell Movement; Adenosine

같은 제1저자의 인용 많은 논문 (5)